A Specific and Covalent JNK-1 Ligand Selected from an Encoded Self-Assembling Chemical Library

Article abstract of DOI:10.1002/chem.201701644

We describe the construction of a DNA-encoded chemical library comprising 148 135 members, generated through the self-assembly of two sub-libraries, containing 265 and 559 members, respectively. The library was designed to contain building blocks potentially capable of forming covalent interactions with target proteins. Selections performed with JNK1, a kinase containing a conserved cysteine residue close to the ATP binding site, revealed the preferential enrichment of a 2-phenoxynicotinic acid moiety (building block A82) and a 4-(3,4-difluorophenyl)-4-oxobut-2-enoic acid moiety (building block B272). When the two compounds were joined by a short PEG linker, the resulting bidentate binder (A82-L-B272) was able to covalently modify JNK1 in the presence of a large molar excess of glutathione (0.5 mm), used to simulate intracellular reducing conditions. By contrast, derivatives of the individual building blocks were not able to covalently modify JNK1 in the same experimental conditions. The A82-L-B272 ligand was selective over related kinases (BTK and GAK), which also contain targetable cysteine residues in the vicinity of the active site.

Full text of DOI:10.1002/chem.201701644

A Journal of
Accepted Article
Title: A specific and covalent JNK-1 ligand selected from an encoded
self-assembling chemical library
Authors: Gunther Zimmermann, Ulrike Rieder, Davor Bajic, Sara
Vanetti, Apirat Chaikuad, Stefan Knapp, Jörg Scheuermann,
Martin Mattarella, and Dario Neri
This manuscript has been accepted after peer review and appears as an
Accepted Article online prior to editing, proofing, and formal publication
of the final Version of Record (VoR). This work is currently citable by
using the Digital Object Identifier (DOI) given below. The VoR will be
published online in Early View as soon as possible and may be different
to this Accepted Article as a result of editing. Readers should obtain
the VoR from the journal website shown below when it is published
to ensure accuracy of information. The authors are responsible for the
content of this Accepted Article.
To be cited as: Chem. Eur. J. 10.1002/chem.201701644
Link to VoR: http://dx.doi.org/10.1002/chem.201701644
Supported by

10.1002/chem.201701644
Chemistry - A European Journal
A specific and covalent JNK-1 ligand selected from an encoded self-assembling chemical
library
Gunther Zimmermann1#, Ulrike Rieder2#, Davor Bajic1, Sara Vanetti2, Apirat Chaikuad3,4,
Stefan Knapp3,4, Jörg Scheuermann1, Martin Mattarella2*, Dario Neri1*
1) Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology
(ETH Zürich), Vladimir-Prelog-Weg 4, CH-8093 Zürich (Switzerland)
2) Philochem AG, Libernstrasse 3, CH-8112 Otelfingen (Switzerland)
3) Institute of Pharmaceutical Chemistry and Buchmann Institute for Life Sciences (BMLS),
Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt (Germany)
4) Nuffield Department of Clinical Medicine, Structural Genomics Consortium and Target
Discovery Institute, University of Oxford, Old Road Campus Research Building, Roosevelt
Drive, Oxford, OX3 7DQ, UK
#) Equal contribution
*) Corresponding Authors
MM: Tel: +41-43-5448817; e-mail: martin.mattarella@philochem.ch
DN: Tel: +41-44-6337401; e-mail: neri@pharma.ethz.ch
Submitted to Chemistry (a European Journal) as Communication
1
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
Abstract
We describe the construction of a DNA-encoded chemical library comprising 148’135
members, generated through the self-assembly of two sub-libraries, containing 265 and 559
members, respectively. The library was designed to contain building blocks potentially capable
of forming covalent interactions with target proteins. Selections performed against JNK1, a
kinase containing a conserved cysteine residue close to the ATP binding site, revealed the
preferential enrichment of a 2-phenoxynicotinic acid moiety (building block A82) and a 4-(3,4-
difluorophenyl)-4-oxobut-2-enoic acid moiety (building block B272). When the two
compounds were joined by a short PEG linker, the resulting bidentate binder (A82-L-B272)
was able to covalently modify JNK1 in the presence of a large molar excess of glutathione (0.5
mM), used to simulate intracellular reducing conditions. By contrast, derivatives of the
individual building blocks were not able to covalently modify JNK1 in the same experimental
conditions. The A82-L-B272 ligand was selective over related kinases (BTK and GAK), which
also contain targetable cysteine residues in the vicinity of the active site.
2
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
DNA-encoded chemical libraries are collections of compounds, individually coupled to DNA
[1]
fragments, serving as amplifiable identification barcodes.
The technology facilitates the
construction and screening of very large compound libraries, in analogy to what routinely
practiced using encoded combinatorial libraries of peptides, proteins or nucleic acids (e.g.,
phage display libraries, yeast display libraries, mRNA display libraries, ribosome display
libraries, aptamer libraries). [2]
A distinction is often made between “single pharmacophore” and “dual pharmacophore”
chemical libraries. In the first case, individual compounds (no matter how complex) are
coupled to a DNA fragment, which serves as amplifiable identification barcode. In the second
case, two building blocks are simultaneously connected to the extremities of complementary
DNA strands, thus enabling the formation of combinatorial libraries by the self-assembly of
[3]
oligonucleotide conjugates. We have recently described a strategy for the encoding of dual-
pharmacophore libraries (also called “encoded self-assembling chemical libraries”, or ESAC
libraries), which was compatible with library decoding procedures, based on high-throughput
[4]
DNA sequencing.
ESAC libraries may facilitate the identification of synergistic building
blocks, which recognize adjacent pockets on target proteins of interest. These chemical
moieties need to be subsequently connected through a suitable chemical linker, in order to
display protein binding in the absence of DNA. [4, 5, 6]
Encoded chemical libraries have previously been used for the discovery of covalent protein
binders. For example, Nicolas Winssinger and coworkers previously reported the identification
[7] [8]
of reversible and irreversible covalent binders of bromodomain, kinases, proteases and
[9]
phosphatases from both DNA and PNA encoded chemical libraries. Recently, Cuozzo et al.
3
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
published the discovery of a potent covalent inhibitor of Bruton’s tyrosine kinase (BTK), with
picomolar IC50 value from a single DNA encoded library. [10]
Here, we describe the construction of a DNA-encoded self-assembling chemical library,
formed by combination of 265 x 559 building blocks, yielding an ESAC library with 148’135
members. The library was designed to incorporate building blocks, which were potentially
capable of forming covalent interactions with certain amino acid residues. Selections performed
against JNK1 (a protein kinase containing seven cysteine residues, of which one conserved
[11]
Cys-116 located in close proximity to the ATP binding site)
led to the identification of two
synergistic building blocks (A82 = 2-phenoxynicotinic acid; B272 = 4-(3,4-difluorophenyl)-4-
oxobut-2-enoic acid). The conjugate A82-L-B272, obtained by joining the two carboxylic acids
with a polyethyleneglycol homobifunctional cross-linker, was able to potently and selectively
modify JNK1 through Michael addition with 1:1 stoichiometry, in the presence of a large molar
excess of glutathione, used to simulate the thiol-rich intracellular environment.
Figure 1 illustrates the procedure used for the construction and encoding of an ESAC library,
featuring building blocks capable of covalent bond formation with protein targets. Two
sublibraries (comprising 265 and 559 members, respectively) were synthesized by covalent
modification of primary amino groups, introduced at the 5’ or 3’ extremities of partially
complementary oligonucleotides. The code for oligonucleotides in Sublibrary B (carrying a
chemical modification at the 3’ end) was introduced by a ligation procedure as previously
[4]
described. These oligonucleotides contained a short abasic site, allowing the hybridization
with members of Sublibrary A. A Klenow polymerization step generated the final and fully
4
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
encoded library, in which each building block pair was unambiguously identified by two
oligonucleotide stretches in Sublibrary A members [Figure 1].
Figure 2 shows the results of a selection performed against biotinylated recombinant JNK1,
[12]
immobilized on streptavidin-coated magnetic beads.
A plot of sequence counts for the
individual library members (identified through the combination of codes A and B), revealed a
preferential enrichment of the A82/B272 pair (641 counts, compared to an average count of
7.7). By contrast, the unselected library displayed an even distribution of sequence counts,
while selections performed against “positive control” proteins (e.g., carbonic anhydrase IX,
horseradish peroxidase) revealed a preferential enrichment of known ligands, which had been
introduced as building blocks [Supplementary Figure S1]. Building block B272 (4-(3,4-
difluorophenyl)-4-oxobut-2-enoic acid) is a Michael acceptor, which can potentially form a
covalent bond with cysteine residues or other thiol-containing compounds. We joined the A82
and B272 moieties through a short polyethylene glycol linker, yielding the A82-L-B272
compound, whose binding properties were further characterized and compared to the ones of
the individual building blocks [Figure 3].
In order to simulate the thiol-rich intracellular milieu, we tested the ability of A82-L-B272 or
of individual building blocks to covalently modify JNK1 (present at 400 nM concentration), in
the presence of a large molar excess of glutathione (500 µM), by mass spectrometry [Figure
3A-C]. JNK1 contains seven cysteine residues, of which one is close to the active site. At a 1.6
µM concentration, A82-L-B272 was able to covalently modify JNK1 with 1:1 stoichiometry
and 75% yield, while no adduct was detectable for A82 or the B272-PA derivative [Figure
3D]. The formation of a 1:1 adduct between A82-L-B272 and JNK1 could be brought to
5
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
completion by using a 3 µM concentration of the ligand, with an apparent dissociation constant
of 1 µM [Figure 3E]. Omission of glutathione in the binding reaction led to the formation of
[13]
adducts with 2:1 stoichiometry [Figure 3D]. Importantly, BTK
and Cyclin G-associated
[14]
kinase (GAK),
two kinases with cysteine residues in the active site, did not exhibit any
detectable covalent modification with A82-L-B272 under the same reaction conditions [Figure
3D], thus providing additional evidence for the JNK1 selectivity of that compound.
6
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
In conclusion, an encoded self-assembling chemical library, comprising 148’135 members, was
constructed and used for the discovery of covalent ligand to JNK1, a protein of the c-Jun N-
terminal protein kinase subfamily, which belongs to the mitogen-activated protein kinase
[15]
(MAPK) superfamily.
JNKs specifically phosphorylate the transcription factor c-Jun on its
N-terminal transactivation domain at two serine residues, Ser-63 and Ser-73, resulting in
enhancement of c-Jun dependent transcriptional events. [16] Subsequent studies have shown that
JNKs also regulate the activity of other transcription factors, including ATF2, c-Myc, JunB and
[17]
p53.
The JNK subfamily is primarily responsive to cytokine stimulation and environmental
stress ranging from osmotic shock to ionizing radiation. JNKs have shown cell type specific
pro- or antiapoptotic functions, mainly depending on the duration of its activation and the
[18]
activity of other signaling pathways.
The importance of JNKs in many pathological
conditions has stimulated pharmaceutical activities, for the discovery of small molecule
inhibitors. [19]
The discovery of molecules capable of selective modification of specific cysteine residues in a
thiol-rich environment (such as the cell cytoplasm) represents a formidable challenge, because
of the high concentration of glutathione which could potentially act as a competitor. Ibrutinib, a
potent and selective covalent inhibitor of BTK, is an effective monotherapy for chronic
lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and Waldenstrom’s
[20]
macroglobulinemia.
The inhibition mechanism consists in the formation of a covalent bond
between the α,β-unsaturated ketone present in the the Ibrutinib structure and Cys-481 in the
active site of the target enzyme. [21]
7
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
In summary, we have shown that ESAC technology may facilitate the discovery of covalent
ligands for proteins of pharmaceutical interest, in thiol-rich experimental conditions. The
building block A82 facilitates the docking of the synergistic binding partner B272, thus
allowing the 1:1 modification of JNK1, in the presence of a >1000-fold molar excess of
glutathione. It is conceivable that additional potency gain may be obtained, replacing the
flexible polyethylene glycol linker with more geometrically constrained scaffolds. Structural
information could facilitate such design activities.
Experimental Section
Full experimental details are given in the Supporting Information.
Acknowledgments
Funding from ETH Zürich, the Swiss National Science Foundation (CRSII2_160699 and
310030B_163479/1), European Research Council (ERC) under the European Union’s Horizon
2020 research and innovation program (grant agreement No 607603), Philochem AG and is
gratefully acknowledged. SK is grateful for financial support by the SGC, a registered charity
(number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim,
Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through
Ontario Genomics Institute, Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of
Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP,
Takeda and the Wellcome Trust.
8
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
References
[1] a) R. A. Lerner, S. Brenner Angew. Chem. Int. Ed. 2017, 56, 1664–1165; b) L. H. Yuen,
Franzini R. M. ChemBioChem 2016, DOI: 10.1002/cbic.201600567; c) G. Zimmermann, D.
Neri, Drug Discov. Today 2016, 21, 1828–1834; d) R. E. Kleiner, C. E. Dumelin, D. R. Liu
Chem. Soc. Rev. 2011, 40, 5707–5717; e) B. Shi, Y. Zhou, Y. Huang, J. Zhang, X. Li Bioorg.
Med. Chem. Lett. 2017, 27, 361–369; f) C. Zambaldo, S. Barluenga, N. Winssinger Curr. Opin.
Chem. Biol. 2015, 26, 8–15; g) P. Blakskjaer, T. Heitner, N. J. V. Hansem Curr. Opin. Chem.
Biol. 2015, 26, 62–71; h) M. A. Clark, R. A. Acharya, C. C. Arico–Muendel, S. L.
Belyanskaya, D. R. Benjamin, N. R. Carlson, P. A. Centrella, C. H. Chiu, S. P. Creaser, J. W.
Cuozzo, C. P. Davie, Y. Ding, G. J. Franklin, K. D. Franzen, M. L. Gefter, S. P. Hale, N. J. V.
Hansen, D. I. Israel, J. Jiang, M. J. Kavarana, M.S. Kelley, C. S. Kollmann, F. Li, K. Lind, S.
Mataruse, P. F. Medeiros, J. A. Messer, P. Myers, H. O’Keefe, M. C. Oliff, C. E. Rise, A. L.
Satz, S. R. Skinner, J. L. Svendsen, L. Tang, K. van Vloten, R. W. Wagner, G. Yao, B. Zhao,
B. A. Morgan Nat. Chem. Biol. 2009, 5, 647–654; i) L. K. Petersen, P. Blakskjær, A. Chaikuad,
A. B. Christensen, J. Dietvorst, J. Holmkvist, S. Knapp, M. Kořínek, A. E. Pedersen, S. Röhm,
F. A. Sløk, N. J. V. Hansen Med. Chem. Commun. 2016, 7, 1332–1339.
[2] a) J. McCafferty, A. D. Griffiths, G. Winter, D. J. Chiswell, Nature 1990, 348, 552–554; b)
A. S. Kang, C. F. Barbas, K. D. Janda, S. J. Benkovic, R. A. Lerner, Proc. Natl Acad. Sci. USA
2001, 98, 3750–3755; c) E. T. Boder, K. D. Wittrup Nature Biotechnol. 1997, 15, 553–557; d)
D. S. Wilson, A. D. Keefe, J. W. Szostak Proc. Natl Acad. Sci. USA 2001, 98, 3750–3755; e) J.
Hansen, A. Pluckthun, Proc. Natl Acad. Sci. USA 1997, 94, 4937–4942; f) A. D. Ellington, J.
W. Szostak Nature 1990, 346, 818-822; g) C. Tuerk, L. Gold Science 1990, 249, 505–510.
[3] a) S. Melkko, J. Scheuermann, C. E. Dumelin, D. Neri Nature Biotechnol. 2004, 22, 568–
574; b) S. Melkko, C. E. Dumelin, J. Scheuermann, D. Neri Chem. Biol. 2006, 13, 225–231.
9
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
[4] M. Wichert, N. Krall, W. Decurtins, R. M. Franzini, F. Pretto, P. Schneider, D. Neri, J.
Scheuermann Nat. Chem. 2015, 7, 241–249.
[5] S. Melkko, Y. Zhang, C. E. Dumelin, J. Scheuermann, D. Neri Angew. Chem. Int. Ed. 2007,
46, 4671–4674.
[6] a) J. -P. Daguer, C. Zambaldo, M. Ciobanu, P. Morieux, S. Barluenga, N. Winssinger
Chem. Sci. 2015, 6, 739–744; b) S. Barluenga, C. Zambaldo, H. A. Ioannidou, M. Ciobanu, P.
Morieux, J. -P. Dauguer, N. Winssinger Bioorg. Med. Chem. Lett. 2016, 26, 1080–1085.
[7] J. -P. Daguer, C. Zambaldo, D. Abegg, S. Barluenga, C. Tallant, S. Mueller, A. Adibekian,
N. Winssinger Angew. Chem. Int. Ed. 2015, 54, 6057–6061.
[8] C. Zambaldo, J. -P. Daguer, J. Saarbach, S. Barluenga, N. Winssinger Med. Chem.
Commun. 2016, 7, 1340–1351.
[9] F. Dabaene, J. A. Da Silva, Z. Pianowski, F. J. Duran, N. Winssinger Tetrahedron 2007, 63,
6577–6586.
[10] J. W. Cuozzo, P. A. Centrella, D. Gikunju, S. Habeshian, C. D. Hupp, A. D. Keefe, E. A.
Sigel, H. H. Soutter, H. A. Thomson, Y. Zhang, M. A. Clark ChemBioChem 2017, DOI:
20.1002/cbic.201600573.
[11] T. Nakaniwa, H. Fukada, T. Inoue, M. Gouda, R. Nakai, Y. Kirii, M. Adachi, T. Tamada,
S. Segawa, R. Kuroki, T. Tada, T. Kinoshita Biochemistry 2012, 51, 8410–8421.
[12] W. Decurtins, M. Wichert, R. M. Franzini, F.Buller, M. A. Stravs, Y. Zhang, D. Neri, J.
Scheuermann Nat. Protoc. 2016, 11, 764–780.
[13] D. J. Marcotte, Y. –T. Liu, R. M. Arduini, C. A. Hession, K. Miatkowski, C. P. Wildes, P.
F. Cullen, V. Hong, R. T. Hopkins, E. Mertsching, T. J. Jenkins, M. J. Romanowski, D. P.
Baker, L. F. Silvian Protein Sci. 2010, 19, 429–439.
[14] S. H. Kimura, H. Tsuruga, N. Yabuta, Y. Endo, H. Nojima Genomics 1997, 44, 179–187.
10
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
[15] G. Pearson, F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, M. H.
Cobb Endocr. Rev. 2001, 22, 153–183.
[16] a) A. Minden, A. Lin, T. Smeal, B. Dérijard, M. Cobb, R. Davis, M. Karin Mol. Cell Biol.
1994, 14, 6683–6688; b) M. A. Bogoyevitch, B. Kobe Microbiol. Mol. Biol. Rev. 2006, 70,
1061–1095.
[17] a) A. L. Adamson, D. Darr, E. Holley-Guthrie, R. A. Johnson, A. Mauser, J. Swenson, S.
Kenney J. Virol. 2000, 74, 1224-1233; R. J. Davis Cell 2000, 103, 239–252; b) L. Chang, M.
Karin Nature 2001, 410, 37–40; c) M. Karin J. Biol. Chem. 1995, 270, 16483–16486; d) J. Liu,
A. Lin Cell Res. 2005, 15, 36–42.
[18] a) Z. G. Liu, H. Hsu, D. V. Goeddel, M. Karin Cell 1996, 87, 565–576; b) M. Verheij, R.
Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M.
Kyriakis, A. Haimovitz-Friedman, Z. Fuks, R. N. Kolesnick Nature 1996, 380, 75–9.
[19] a) J. Cicenas MAP Kinases 2015, 4, 32–35; b) R. Yarza, S. Vela, M. Solas, M. J. Ramirez
Front. Pharmacol. 2016, 6, 321–332; c) G. Solinas, B. Becattini Mol. Metab. 2017, 6, 174–
184; d) R. Roskoski Jr. Pharmacol. Res. 2016, 111, 784–803.
[20] a) J. A. Burger, A. Tedeschi, P. M. Barr, T. Robak, C. Owen, P. Ghia, O. Bairey, P.
Hillmen, N. L. Bartlett, J. Li, D. Simpson, S. Grosicki, S. Devereux, H. McCarthy, S. Coutre,
H. Quach, G. Gaidano, Z. Maslyak, D. A. Stevens, A. Janssens, F. Offner, J. Mayer, M.
O’Dwyer, A. Hellmann, A. Schuh, T. Siddiqi, A. Polliack, C. S. Tam, D. Suri, M. Cheng, F.
Clow, L. Styles, D. F. James, T. J. Kipps N. Engl. J. Med. 2015, 373, 2425–2437; b) M. Cinar,
F. Hamedani, Z. Mo, B. Cinar, H. Amin, S. Alkan Leuk. Res. 2013, 37, 1271–1277; c) J. J.
Castillo, M. L. Palomba, R. Advani, S. P. Treon Ther. Adv. Hematol. 2016, 7, 179–186.
[21] E. S. Kim, S. Dhillon Drugs 2015, 75, 769–776.
11
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
Figure Captions
Figure 1: Design and encoding of the dual-display DNA-encoded chemical library. (A)
Overview of library construction. The synthesis of Sublibrary A (red) was performed by
coupling a chemical fragment to an oligonucleotide with a distinct coding sequence that
unambiguously identifies each individual library member. The conjugates were individually
purified and characterized by LC-MS. The Sublibrary A is composed of 265 members, of
which 42 are capable of covalent bond formation. The synthesis of Sublibrary B (blue) has
[4]
been described previously and was extended with additional 359 building blocks, of which
114 are capable of covalent bond formation. With the help of an adapter, the conjugates were
encoded by ligation to code B oligonucleotides. Sublibrary B was hybridized with Sublibrary A
and Klenow polymerase-assisted fill-in reaction allowed the code transfer onto the Sublibrary
A strand to form the final library of 148’135 members. (B) Schematic representation of a
12
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
member of the dual-display library binding to a target protein. The library is formed by
hybridization of two individually synthesized sublibraries A and B, resulting in a combinatorial
library A × B.
Figure 2: Selection results from the 148’135-member dual-display library. High-throughput
DNA sequencing (HTDS) plot of selections against JNK1. The x–y plane represents library
member barcodes of Sublibrary A and Sublibrary B, and the z axis shows the sequence counts
(cutoff level = 200). The most enriched fragment pair corresponds to A82 (in Sublibrary A) and
B272 (in Sublibrary B).
13
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
Figure 3: Mass analysis assay for covalent JNK1 binder. (A) Schematic overview of the MS
analysis assay for the detection of covalently modified JNK1 protein in the presence or absence
of glutathion. (B) The most enriched fragment pair A82 and B272 connected with a short
polyethyleneglycol-linker A82-L-B272 and the compound B-272 modified with a simple
propylamine used as a monovalent control compound B272-PA. (C) A82-L-B272 treated JNK1
kinase domain. Mass spectra were obtained after deconvolution and show addition of 539
14
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
Daltons after incubation with A82-L-B282. Assay conditions: 0.4 µM JNK1 in 50 mM HEPES,
300 mM NaCl, 10 mM MgCl2, 1 µM TCEP; 0.5 mM glutathion; 3.0 µM A82-L-B282. (D) Hit
validation of selected building block pair against JNK1, BTK and GAK. By MS analysis,
monovalent A82 and B272-PA show no detectable (n.d.) JNK1 modification. Assay conditions:
0.4 µM JNK1/GAK in 50 mM HEPES, 300 mM NaCl, 10 mM MgCl2, 1 µM TCEP; 0.4 µM
BTK in 20 mM Tris, 240 mM NaCl, 30 µM DTT; +/− glutathion (GSH, 0.5 mM); 1.6 µM
binder. Error bars indicate standard deviations of three independent measurements. (E)
Titration of JNK1 with increasing concentration of binder A82-L-B272. Titration conditions:
0.4 µM JNK1 in 50 mM HEPES, 300 mM NaCl, 10 mM MgCl2, 1 µM TCEP; glutathion
(GSH, 0.5 mM); 0.1 - 4.0 µM binder A82-L-B272. Error bars indicate deviations of two
independent measurements.
15
This article is protected by copyright. All rights reserved.

10.1002/chem.201701644
Chemistry - A European Journal
COMMUNICATION
Gunther Zimmermann#, Ulrike Rieder#,
Davor Bajic, Sara Vanetti, Apirat Chaikuad,
Stefan Knapp, Jörg Scheuermann, Martin
Mattarella*, Dario Neri*
Page No. – Page No.
A specific and covalent JNK-1 ligand
selected from an encoded self-
assembling chemical library
A novel covalent binder of JNK1, a kinase containing seven cysteine residues
one of which conserved and close to the ATP binding site, has been identified from
a DNA encoded self-assembling chemical library (ESAC). The binder showed the
ability to covalently modify JNK1 in a 1:1 stoichiometry in presence of a large molar
excess of glutathione to mimic the intracellular reducing environment.
16
This article is protected by copyright. All rights reserved.